Skip to main content
. 2020 Dec 7;9:285. doi: 10.1186/s13643-020-01540-1

Table 2.

Percentage of grade 3 and above adverse events

graphic file with name 13643_2020_1540_Tab2_HTML.jpg

Colour code: blue = 0 to 25%, purple = 26 to 50%, orange = 51 to 75% and red = 76 to 100%

Abbreviations: cont control, gilt gilteritinib, lest lestaurtinib, mido midostaurin, quiz quizartinib, sora sorafenib

*Includes patients from both AML15 and AML17 lestaurtinib trials following course 2 induction therapy